Markers for Identifying and Targeting Glioblastoma Cells during Surgery

被引:13
|
作者
Schipmann, Stephanie [1 ]
Schwake, Michael [1 ]
Molina, Eric Suero [1 ]
Stummer, Walter [2 ]
机构
[1] Univ Hosp Munster, Dept Neurosurg, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany
[2] UK Munster, NCH, Munster, Germany
关键词
glioma; interoperative MRI; 5-ALA; fluorescein; indocyanine green; HIGH-GRADE GLIOMAS; FLUORESCENCE-GUIDED RESECTION; GROSS TOTAL RESECTION; INDOCYANINE GREEN VIDEOANGIOGRAPHY; SURGICAL MICROSCOPE FILTER; PROSPECTIVE PHASE-II; BRAIN-TUMOR SURGERY; 5-AMINOLEVULINIC ACID; VOLUMETRIC-ANALYSIS; MALIGNANT GLIOMAS;
D O I
10.1055/s-0039-1692976
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glioblastoma is a highly malignant tumor with a poor prognosis. A factor influencing survival that can be affected by the surgeon is the extent of resection (EOR). Due to the infiltrative nature of the tumor, delineation of tumor from normal brain parenchyma is often challenging. To improve EOR and facilitate tumor visualization, several techniques have been developed over the last few years. This literature review presents an overview of current intraoperative strategies for identifying and targeting glioma cells and discusses the benefits and limitations of each technique. Along with conventional techniques such as neuronavigation and ultrasound, fluorescence-guided surgery with different fluorescent agents such as 5-aminolevulinc acid and fluorescein have been widely used. Recently, newer techniques have emerged and are being translated into the operating room, promising delineation of glioblastoma tissue using targeted approaches or identification on a microscopic level, for instance using Raman spectroscopy or confocal microscopy.
引用
收藏
页码:475 / 487
页数:13
相关论文
共 50 条
  • [41] Molecular targeting of glioblastoma: Drug discovery and therapies
    Bai, Ren-Yuan
    Staedtke, Verena
    Riggins, Gregory J.
    TRENDS IN MOLECULAR MEDICINE, 2011, 17 (06) : 301 - 312
  • [42] Targeting adaptive glioblastoma: an overview of proliferation and invasion
    Xie, Qian
    Mittal, Sandeep
    Berens, Michael E.
    NEURO-ONCOLOGY, 2014, 16 (12) : 1575 - 1584
  • [43] Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma
    Cornelison, Robert
    Marrah, Laine
    Horter, Drew
    Lynch, Sarah
    Li, Hui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [44] Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma
    Taylor, Matthew A.
    Das, Bhaskar C.
    Ray, Swapan K.
    APOPTOSIS, 2018, 23 (11-12) : 563 - 575
  • [45] Targeting Glioblastoma: Advances in Precision Drug Delivery
    Rajendran, Arunraj Tharamelveliyil
    Vadakkepushpakath, Anoop Narayanan
    JOURNAL OF YOUNG PHARMACISTS, 2024, 16 (04) : 697 - 705
  • [46] The limitations of targeting MEK signalling in Glioblastoma therapy
    Selvasaravanan, Karthika D.
    Wiederspohn, Nicole
    Hadzalic, Amina
    Strobel, Hannah
    Payer, Christel
    Schuster, Andrea
    Karpel-Massler, Georg
    Siegelin, Markus D.
    Halatsch, Marc-Eric
    Debatin, Klaus-Michael
    Westhoff, Mike-Andrew
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [47] Targeting Glioblastoma: The Current State of Different Therapeutic
    Khan, Imran
    Mahfooz, Sadaf
    Elbasan, Elif Burce
    Karacam, Busra
    Oztanir, Mustafa Namik
    Hatiboglu, Mustafa Aziz
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (10) : 1701 - 1715
  • [48] Wnt pathway markers in molecular subgroups of glioblastoma
    Tompa, Marton
    Nagy, Adam
    Komoly, Samuel
    Kalman, Bernadette
    BRAIN RESEARCH, 2019, 1718 : 114 - 125
  • [49] Expression of markers of neural stem and progenitor cells in glioblastoma multiforme in relation to tumor recurrence and overall survival
    Wankowicz, Pawel
    Roginska, Dorota
    Machalinski, Boguslaw
    Nowacki, Przemyslaw
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (02) : 481 - 483
  • [50] Targeting CDK9 for the Treatment of Glioblastoma
    Ranjan, Alice
    Pang, Ying
    Butler, Madison
    Merchant, Mythili
    Kim, Olga
    Yu, Guangyang
    Su, Yu-Ting
    Gilbert, Mark R.
    Levens, David
    Wu, Jing
    CANCERS, 2021, 13 (12)